Shalby Ltd
NSE:SHALBY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
210.59
323.05
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shalby Ltd
Note Receivable
Shalby Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shalby Ltd
NSE:SHALBY
|
Note Receivable
₹180.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Note Receivable
₹3.6B
|
CAGR 3-Years
18%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Note Receivable
₹8.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Note Receivable
₹5.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Note Receivable
₹4.3B
|
CAGR 3-Years
88%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Note Receivable
₹899.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shalby Ltd
Glance View
Shalby Ltd. engages in the operation of hospitals and outpatient clinics. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-12-15. The firm is mainly engaged in the business of setting up and managing hospitals and medical diagnostic services. Its Healthcare Services segment includes the business of setting up and managing hospitals and medical diagnostics services. Its Manufacturing segment represents the manufacturing of implants. The company offers tertiary and quaternary healthcare services to patients in various areas of specialization, such as orthopedics, complex joint replacements, cardiology, neurology, oncology and renal transplantations, among others. The company provides tertiary and qua-tertiary medical services, including home healthcare and medics/paramedics educational and training programs. The company is also running home healthcare services to deliver medicines, nurses, attendants and other products at home and also running educational and training programs to upgrade and enhance the skills in healthcare industry.
See Also
What is Shalby Ltd's Note Receivable?
Note Receivable
180.6m
INR
Based on the financial report for Jun 30, 2024, Shalby Ltd's Note Receivable amounts to 180.6m INR.
What is Shalby Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
12%
Over the last year, the Note Receivable growth was -32%. The average annual Note Receivable growth rates for Shalby Ltd have been 5% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
